Answer
Empliciti (elotuzumab) is contraindicated in patients with hypersensitivity to elotuzumab or any of its excipients.
Sources for this answer
- Empliciti 300 mg and 400 mg powder for concentrate for solution for infusionBristol Myers Squibb Pharmaceuticals limited · emc · SmPC §4.3 Contraindications · Version 12Document updated
Sources checked